Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8525971 | Biomedicine & Pharmacotherapy | 2018 | 7 Pages |
Abstract
There was no apparent difference on improving vision between SDMLP monotherapy and CLP monotherapy. The most effective treatment in the network was ranibizumab therapy combined with CLP followed by SDMLP monotherapy, Bevacizumab therapy combined with CLP, and CLP monotherapy in rank order.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ying Wu, Pu Ai, Zisheng Ai, Guotong Xu,